- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 34.92M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $56M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $60.6M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $627K |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $1.32M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $3.66M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $7.06M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $103.8M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $91.71M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $182.85M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $175.39M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $161.73M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $139.83M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $374.22M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $356.36M |
| Rd Expense | Q1 2025 · Mar 31, 2025 | $165K |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $151K |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 34.32M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $2.46M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$7.72M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $156.82M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $155.65M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.10 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.10 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $16.53M |
| Net Income | Q1 2025 · Mar 31, 2024 | $3.29M |